Pulmonx (LUNG) Q1 2026 Earnings Call Transcript Released
Pulmonx (LUNG) released its Q1 2026 earnings call transcript, with management discussing forward-looking statements related to financial performance, clinical trials, and commercial strategies. The call included remarks from CEO Glendon French and CFO Derrick Sung, and a press release with financial results was made available on the company's website.
Tickers: $LUNG
Topics: Company Performance Earnings Call Financial Results Forward-Looking Statements